注射药物使用的医学并发症 - - 第二部分
Katherine M Rich1, Daniel A Solomon1,2
1Harvard Medical School, Boston.
NEJM evidence
|February 6, 2024
概括
注射药物使用导致死亡和住院病例的增加,主要是由于阿片类药物流行. 本综述涵盖了注射药物使用者的医疗并发症和降低危害策略.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 成 药物 药物 药物 药物
背景情况:
- 在过去20年中,在美国注射毒品 (PWID) 的人群中,死亡率和住院率不断上升.
- 阿片类药物流行病对PWID的不良健康结果的重大贡献.
- 需要全面了解医疗并发症和有效减少伤害.
研究的目的:
- 审查与注射药物使用相关的医疗并发症的范围.
- 讨论目前旨在减少PWID之间的伤害的战略.
- 为临床医生和公共卫生专业人员提供最新的概述.
主要方法:
- 对注射药物使用者的医学并发症的文献综述.
- 对死亡率和住院数据趋势的分析.
- 综合基于证据的减少伤害干预措施.
主要成果:
- 注射药物使用与广泛的严重疾病有关.
- 阿片类药物危机加剧了PWID的健康风险和死亡率.
- 各种减少危害的策略显示出减轻不利结果的希望.
结论:
- 解决注射药物使用的医学并发症需要多方面的方法.
- 减少危害的策略对于改善健康结果和降低PWID的死亡率至关重要.
- 持续的研究和基于证据的干预措施的实施是至关重要的.
相关概念视频
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Prevention of Further Absorption of Poison
823
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
823
Diabetes: Symptoms, Diagnosis, and Complications
544
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Drug Delivery: Parenteral Route
532
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
532
Drug Abuse and Addiction: Pharmacological Phenomena
476
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
476
Drug Delivery: Miscellaneous Routes
343
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
343


